2024 Q4 Form 10-Q Financial Statement

#000147793224007429 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $20.09K
YoY Change 67.88%
Operating Profit -$20.09K
YoY Change 67.88%
Interest Expense $32.82K
YoY Change 5.63%
% of Operating Profit
Other Income/Expense, Net -$32.82K
YoY Change 5.63%
Pretax Income -$52.91K
YoY Change 22.94%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$52.91K
YoY Change 22.94%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 7.498M shares 7.498M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $524.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $524.00
YoY Change 38.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $524.00
Total Long-Term Assets $0.00
Total Assets $524.00
YoY Change -99.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $244.4K
YoY Change 22.65%
Accrued Expenses $417.0K
YoY Change 17.87%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $357.6K
YoY Change
Total Short-Term Liabilities $1.605M
YoY Change 13.89%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.605M
Total Long-Term Liabilities
Total Liabilities $1.605M
YoY Change 13.89%
SHAREHOLDERS EQUITY
Retained Earnings -$3.133M
YoY Change 48.95%
Common Stock $7.498K
YoY Change 1.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.604M
YoY Change
Total Liabilities & Shareholders Equity $524.00
YoY Change -99.81%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$52.91K
YoY Change 22.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
5141050 shares
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3571043 shares
us-gaap Net Income Loss
NetIncomeLoss
-704115 usd
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7498305 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Net Income Loss
NetIncomeLoss
-147080 usd
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7361005 shares
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
275000 usd
us-gaap Debt Instrument Convertible Conversion Price Decrease
DebtInstrumentConvertibleConversionPriceDecrease
1.00
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
357625 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
326675 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2024Q3 srsg Accrued Interest On Convertible Notes And Loans Payable
AccruedInterestOnConvertibleNotesAndLoansPayable
181575 usd
CY2023Q4 srsg Accrued Interest On Convertible Notes And Loans Payable
AccruedInterestOnConvertibleNotesAndLoansPayable
164819 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
524 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
493 usd
CY2024Q3 us-gaap Assets
Assets
524 usd
CY2023Q4 us-gaap Assets
Assets
493 usd
CY2024Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
110000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
39751 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
8384 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
31367 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
6356 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7498305 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001434737
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7498305 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7498305 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7498305 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-151300
dei Entity Registrant Name
EntityRegistrantName
SPIRITS TIME INTERNATIONAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3455830
dei Entity Address Address Line1
EntityAddressAddressLine1
1661 Lakeview Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Ogden
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84403
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
399-3632
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7498305 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
524 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
524 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
493 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 usd
CY2024Q3 us-gaap Assets
Assets
524 usd
CY2023Q4 us-gaap Assets
Assets
493 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
244364 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
207775 usd
CY2024Q3 srsg Related Party Transaction Amounts Of Accounts Payable
RelatedPartyTransactionAmountsOfAccountsPayable
4000 usd
CY2023Q4 srsg Related Party Transaction Amounts Of Accounts Payable
RelatedPartyTransactionAmountsOfAccountsPayable
9500 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
417036 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
351285 usd
CY2024Q3 srsg Related Party Transaction Amounts Of Accrued Interest
RelatedPartyTransactionAmountsOfAccruedInterest
181575 usd
CY2023Q4 srsg Related Party Transaction Amounts Of Accrued Interest
RelatedPartyTransactionAmountsOfAccruedInterest
164819 usd
CY2024Q3 srsg Related Party Transaction Amounts Of Transaction Loans Payable
RelatedPartyTransactionAmountsOfTransactionLoansPayable
302625 usd
CY2023Q4 srsg Related Party Transaction Amounts Of Transaction Loans Payable
RelatedPartyTransactionAmountsOfTransactionLoansPayable
271675 usd
CY2024Q3 srsg Related Party Transaction Amounts Of Transaction Of Convertible Notes Payable
RelatedPartyTransactionAmountsOfTransactionOfConvertibleNotesPayable
55000 usd
CY2023Q4 srsg Related Party Transaction Amounts Of Transaction Of Convertible Notes Payable
RelatedPartyTransactionAmountsOfTransactionOfConvertibleNotesPayable
55000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
110000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
85000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1604600 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1435054 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1604600 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1435054 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7498305 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
7498 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7498 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1520754 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
986354 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3132983 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2428868 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1604076 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1434561 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
524 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
493 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
17843 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
9714 usd
us-gaap Professional Fees
ProfessionalFees
599563 usd
us-gaap Professional Fees
ProfessionalFees
47501 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2246 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2252 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8045 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8512 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
20089 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11966 usd
us-gaap Operating Expenses
OperatingExpenses
607608 usd
us-gaap Operating Expenses
OperatingExpenses
56013 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20089 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11966 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-607608 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-56013 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
32817 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
31067 usd
us-gaap Interest Expense
InterestExpense
96507 usd
us-gaap Interest Expense
InterestExpense
91067 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32817 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31067 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-96507 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-91067 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52906 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43033 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-704115 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-147080 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-52906 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43033 usd
us-gaap Net Income Loss
NetIncomeLoss
-704115 usd
us-gaap Net Income Loss
NetIncomeLoss
-147080 usd
CY2024Q3 srsg Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.01
CY2023Q3 srsg Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.01
srsg Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.09
srsg Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.02
CY2024Q3 srsg Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7498305 shares
CY2023Q3 srsg Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7361005 shares
srsg Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7498305 shares
srsg Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7361005 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1434561 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-50988 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1485549 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
534600 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-600221 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1551170 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-52906 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1604076 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-986414 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-50151 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1036565 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-53896 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1090461 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43033 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1133494 usd
us-gaap Profit Loss
ProfitLoss
704115 usd
us-gaap Profit Loss
ProfitLoss
147080 usd
us-gaap Share Based Compensation
ShareBasedCompensation
534600 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102340 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
84503 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-5500 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-2500 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
16756 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27397 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55919 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37680 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30950 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
27350 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55950 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37350 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
31 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-330 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
707 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
524 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
377 usd
us-gaap Interest Paid Net
InterestPaidNet
14000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30950 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
27350 usd
CY2024Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12 pure
CY2024Q3 us-gaap Loans Payable
LoansPayable
302625 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
271675 usd
CY2024Q3 srsg Accrued Interest Related Parties
AccruedInterestRelatedParties
122153 usd
CY2023Q4 srsg Accrued Interest Related Parties
AccruedInterestRelatedParties
110338 usd
us-gaap Interest Expense Other
InterestExpenseOther
14000 usd
us-gaap Interest Expense Other
InterestExpenseOther
0 usd
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55000 usd
CY2024Q3 srsg Accuredinterest Current
AccuredinterestCurrent
59422 usd
CY2023Q4 srsg Accuredinterest Current
AccuredinterestCurrent
54481 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
302625 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
271675 usd
CY2024Q3 srsg Convertible Notes And Loans Payable Related Parties
ConvertibleNotesAndLoansPayableRelatedParties
357625 usd
CY2023Q4 srsg Convertible Notes And Loans Payable Related Parties
ConvertibleNotesAndLoansPayableRelatedParties
326675 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
85000 usd
CY2024Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
110000 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
85000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd

Files In Submission

Name View Source Status
0001477932-24-007429-index-headers.html Edgar Link pending
0001477932-24-007429-index.html Edgar Link pending
0001477932-24-007429.txt Edgar Link pending
0001477932-24-007429-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srsg-20240930.xsd Edgar Link pending
srsg_10q.htm Edgar Link pending
srsg_ex311.htm Edgar Link pending
srsg_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
srsg-20240930_cal.xml Edgar Link unprocessable
srsg-20240930_def.xml Edgar Link unprocessable
srsg-20240930_lab.xml Edgar Link unprocessable
srsg-20240930_pre.xml Edgar Link unprocessable
srsg_10q_htm.xml Edgar Link completed